SCHEMBL5073221

SCHEMBL5073221

CC(C)(C)CCCCCCCC(C=O)O[SiH](c1ccccc1)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4528482 0.94 RIPK1 (0.37) RIPK1
SCHEMBL8391276 0.80
SCHEMBL19305259 0.76
SCHEMBL8070765 0.69 PPARA (0.33) RIPK1
SCHEMBL8559419 0.69 RIPK1 (0.43) RIPK1
SCHEMBL9569520 0.68 ATM (0.30)
SCHEMBL702654 0.68 RIPK1 (0.34) RIPK1
SCHEMBL5079143 0.68 PPARA (0.39)
SCHEMBL8075407 0.68 PPARA (0.36) RIPK1
SCHEMBL28914670 0.67 RIPK1 (0.38) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348173-B2 Fatty-acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2008-03-25 US disclosed
EP-0970195-B1 FATTY-ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2007-10-17 EP disclosed
EP-0833899-B1 CIS-9,10-OCTADECENOAMIDASE SCRIPPS RESEARCH INST (US) 2005-01-19 EP disclosed
US-20040265958-A1 that hydrolyzes fatty amides such as cis-9,10-octadecenoamide to neutralize the soporific activity of the fatty amides; enzyme inhibitors for use in treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE 2004-12-30 US disclosed
US-6699682-B2 ENZYMATIC POLYPEPTIDE FOR USE IN THE TREATMENT OF SLEEP DISORDERS THE SCRIPPS RESEARCH INSTITUTE 2004-03-02 US disclosed
US-20020187542-A1 Fatty-acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2002-12-12 US disclosed
EP-0970195-A4 FATTY-ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2001-12-05 EP disclosed
US-6271015-B1 A POLYPEPTIDE HAVING AN AMINO ACID SEQUENCE THAT HYDROLYSIZES CIS-9,10-OCTADECENOAMIDE AND OTHER SOPORIFIC FATTY ACID AMIDES; THERAPY FOR SLEEP DISORDERS AND NARCOLEPSY THE SCRIPPS RESEARCH INSTITUTE 2001-08-07 US disclosed
EP-0833899-A4 CIS-9,10-OCTADECENOAMIDASE SCRIPPS RESEARCH INST (US) 2000-06-28 EP disclosed
EP-0970195-A1 FATTY-ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2000-01-12 EP disclosed
WO-1998020119-A9 FATTY-ACID AMIDE HYDROLASE 1998-11-05 WO disclosed
WO-1998020119-A1 FATTY-ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 1998-05-14 WO disclosed
EP-0833899-A1 CIS-9,10-OCTADECENOAMIDASE THE SCRIPPS RESEARCH INSTITUTE (US) 1998-04-08 EP disclosed
WO-1996041869-A1 CIS-9,10-OCTADECENOAMIDASE THE SCRIPPS RESEARCH INSTITUTE (US) 1996-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040265958-A1 that hydrolyzes fatty amides such as cis-9,10-octadecenoamide to neutralize the soporific activity of the fatty amides; enzyme inhibitors for use in treating sleep disorders FAAH, FAAH2, APEH RIPK1 3506/4885
US-20020187542-A1 Fatty-acid amide hydrolase FAAH, FAAH2, APEH RIPK1 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.